GL1X · GenesisL1 explorer

MolNFT v1 · #156955 · protein

Crystallographic solvent mapping analysis of dmso bound to APE1

6MK3 · DNA-(apurinic or apyrimidinic site) lyase: “Crystallographic solvent mapping analysis of dmso bound to APE1”. X-ray diffraction, 2 pockets (best druggability 0.42). MolNFT v1 #156955 on GenesisL1: 3D structure, binding sites and…

PDB
6MK3
Type
protein
Length
281 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
DNA-(apurinic or apyrimidinic site) lyase
EC
3.1.-.-, 4.2.99.18
UniProt
P27695
Pockets
2 · best druggability 0.42

Structure

x-ray diffraction · 1 distinct chain · 26% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-, 4.2.99.18)protein28126% helix, 25% strandP27695

Ligands and binding sites

  • EDO · 1,2-ethanediol · additive · 3 copies · chains A
  • DMS · Dimethyl sulfoxide · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11560.420.7438DMS
2620.360.7812empty

Compared structures

  • 6MK3 · Crystallographic solvent mapping analysis of DMSO bound to APE1 · the same entry in another collection · chain A against A, TM-score 1.00
  • P27695 · AlphaFold monomer V2.0 prediction for DNA-(apurinic or apyrimidinic site) endonuclease… · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.